“Response to Glucose Deficiency With Sodium-Glucose Cotransporter 2 Inhibitors Makes a Positive Impact on Heart and Kidney”. 2022. Cardiology and Cardiovascular Medicine 6 (1): 13-18. https://fortunejournals.org/ojs/index.php/ccm/article/view/16192.